Modular Medical, Inc.

Modular Medical, Inc. awarded a total of 15,892 stock options to its Chairman, President, CFO, and Treasurer, Paul DiPerna, and its Chief Operating Officer, Kevin Schmid. The options have an exercise price of $3.46 per share and will vest over time, with one-third vesting on May 14, 2027, and the remainder vesting monthly thereafter. The awards were made under the company's Amended and Restated 2017 Equity Incentive Plan and expire on May 14, 2036.

Modular Medical, Inc. entered into a Placement Agency Agreement with Maxim Group LLC for a registered direct offering. The company plans to sell 750,000 shares of common stock, expecting to raise approximately $3.375 million in gross proceeds. The offering is anticipated to close on April 21, 2026, with the Placement Agent receiving a 7% cash fee and up to $75,000 for expenses.

Modular Medical, Inc. announced it has regained compliance with the Nasdaq Capital Market's minimum bid price requirement. The company received notification from Nasdaq that its common stock maintained a closing bid price above the $1.00 minimum for 10 consecutive trading days as of April 14, 2026, resolving the compliance matter.